Answers are grounded in this paper and cite their sources.
We report on 2 critically ill patients with pneumonitis and acute respiratory distress syndrome due to pandemic (H1N1) 2009 influenza A virus who were treated with intravenous zanamivir and had favorable clinical outcomes. Zanamivir given intravenously may be a therapeutic option in patients with critical illness and mechanical ventilation.
No takes yet. Share an insight, caveat, or question.
Härter et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: